Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
122
Journal Issue
7
Pages
564
Date Issued
2023-07
Abstract
Distinct hepatitis relapse has been observed after discontinuing entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy in chronic hepatitis B (CHB) patients. End-of-therapy (EOT) serum cytokines were compared and used for outcome prediction.
Subjects
Antiviral therapy; Chronic hepatitis B; Cytokine; Hepatitis flare; Nucleos(t)ide analogue
Type
journal article